🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It’s out! After 14+ long years of enrollment, analysis and follow up the CoMMpass trial is published in full format nam11.safelinks.protection.outlook.com/?url=https%3A%…. Thanks to J Keats, all the investigators, Multiple Myeloma RF and to the patients who were part of this landmark study.

Dear Friends Tata Memorial Centre, Parel, Mumbai, The Leukemia, Lymphoma Foundation & Myeloma Friends India invites you to attend this seminar on 26th August 2024 at 2.00 PM onwards. We will also share ZOOM link for members from other cities and can not attend physically.

"We have the tools we didn't two decades ago. It is our responsibility to put them together ... and ultimately change the fraction of cured patients!" Listen to Sagar Lonial MD and Joseph Mikhael during the International Myeloma Foundation LA Patient and Family Seminar. #mmsm youtu.be/I0A50u0DYb4?t=…

Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial | Nature Cancer. Bringing checkpoints back to myeloma #mmsm ⁦Multiple Myeloma RF⁩ nature.com/articles/s4301…

British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/bj… Can baseline GPS (CRP, albumin) and CART HEMATOX (platelet count, absolute neutrophil count, hemoglobin, CRP and ferritin) score predictive outcomes in patients treated with BCMA bsAb ?

Today we kicked off our Iceland Cycling Expedition #MyelomaICE with a visit to decodeGenetics and iStopMM. Thanks Sigurdur Kristinsson for hosting us. Follow us at myeloma.org/ice #mmsm Joseph Mikhael Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Rafat Abonour Sylvia Sánchez International Myeloma Foundation #mmsm

Raising awareness & standing strong this Blood Cancer Awareness Month! Let's unite in the fight, spreading hope & support. Every step toward awareness brings us closer to a cure. Stay informed, stay strong! #myelomafriendsindia #MFCT #kNOwMyeloma #CancerSoWhatOvercomeIt

Dear Friends, We are pleased to invite you to an enlightening seminar on Transplant and Cell Therapy in Multiple Myeloma and Management of Relapsed Refractory Lymphoma in Young. Date: 4th September 2024 Time: 8:00 PM

Join us for the Inaugural Kyle-Barlogie Memorial Sloan Kettering-Mayo Clinic Plasma Cell Disorders Symposium on November 22-23, 2024! This event isapproved for AMA PRA Category 1 Credits™️   Register by October 25th for the early bird discount! We look forward to seeing you

Join us at 7:15 pm on 10th September 2024 for an empowering webinar on ‘A Journey from Diagnosis to Complete Remission' with Dr. Nikita mehra and Dr. Gayatri Bhatt. Learn in simple terms! Scan the barcode or join via Google Meet link.

IMAGe (IMAGe) announces its next journal club on 26 September 2024 at 1730 IST. Please tune in to hear about the recently published article on Cardiac Response Criteria in AL Amyloidosis. Sumeet Mirgh MD, DM Dr. Subhaprakash Sanyal Hari Menon Pankaj Malhotra Shaji Kumar

Excited to see the 3 Ts of myeloma expand to 5 to now reflect the modern era and global care. Congrats to all authors! But sobering to see results: 20% of LATAM #MMsm MDs don’t have SPEP commercially, over half don’t have FLC. More needs to be done! journals.lww.com/co-oncology/ab…

Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma pubmed.ncbi.nlm.nih.gov/39145912/ Darren Pan Joshua Richter, MD, FACP Icahn School of Medicine at Mount Sinai #MultipleMyeloma

Thank you to our incredible IMF team members for your unwavering dedication and compassion. Your tireless work makes a difference in the lives of myeloma patients worldwide. #WorldGratitudeDay

#IMS24 more details on upcoming revisions to how high-risk myeloma #MMsm defined. I’d seen relegation of solo t(4;14) and the re-inclusion of del(1p)… … but now B2M making a new appearance too! (Not just ISS), of course with CKD exclusion. He said manuscript under review!

Indian and International faculties at Rio de Janeiro IMS Myeloma conference. Shaji Kumar Pankaj Malhotra Bhausaheb Bagal Dr sanjeev International Myeloma Foundation IMAGe

Friends, India's first BCMA based CAR T phase 1, Ribre- Cel clinical trial was presented at the 21st International myeloma society, Annual meeting at Rio de Janeiro, Brazil by Dr. Akhilkumar PI and VP of Aurigene oncology All the patients responded well on first evaluation.

#IMS24 see the future of FISH reporting in #MMsm - thanks Linda B. Baughn Vincent Rajkumar Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 for including me 🙏 Consensus manuscript submitted and will hopefully become the norm everywhere! 🐟 specify gain vs amp 1q 🐠 don’t say “atypical abnormal” t(11;14) unless it is t(11;14)!

India's first BCMA based CAR T therapy phase 1 Ribre-Cel trial was presented at the 21st International myeloma society, meeting at Rio de Janeiro, Brazil on 26th Sept 2024 by Dr. Akhilkumar PI and VP of Aurigene oncology. All the patients responded well on first evaluation.

I’m honored to work with Yelak Biru CEO of International Myeloma Foundation Yelak, a myeloma patient himself, has dedicated his life to helping and advocating for patients worldwide. Photo from #IMS2024 in Rio.